Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trivalent Salmonella conjugate vaccine in healthy adults
NCT03981952Phase 1Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Oct 2019
- Primary completion
- May 2021
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of trivalent salmonella conjugate vaccine in salmonellosis, sponsored by University of Maryland, Baltimore. Started Oct 2019; status: completed.
02
Drugs
trivalent salmonella conjugate vaccine
03
Conditions
salmonellosis
Beyond the preview
Go deeper on NCT03981952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03981952.